Explore Vietnam Vaccine Market size, share, revenue, players, outlook, and future growth to 2028 with insights into top players and market opportunities.

Vietnam vaccine market size reached USD 851 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,468 Million by 2033, exhibiting a growth rate (CAGR) of 6.2% during 2025-2033. The increasing awareness about the importance of immunization in preventive healthcare measures, rising prevalence of dengue and hand, foot, and mouth disease, and rapid advancements in vaccine delivery methods represent some of the key factors driving the market.

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2025-2033. Our report has categorized the market based on product type, treatment type, technology, route of administration, patient type, indication, distribution channel, and end user.

The Vietnam vaccine market was valued at USD 3.59 Billion in 2024, driven by the advancements in vaccine technology and robust government initiatives in the region. The market is anticipated to grow at a CAGR of 9.60% during the forecast period of 2025-2034, with the values likely to reach USD 8.98 Billion by 2034.

The Vietnamese vaccine market soared to $466M in 2024, jumping by 76% against the previous year. This figure reflects the total revenues of producers and importers (excluding logistics costs, retail marketing costs, and retailers' margins, which will be included in the final consumer price). Over the period under review, consumption continues to indicate a resilient expansion.

Vietnam Veterinary Vaccines Market is driven by increasing demand for animal-derived food products, rising pet ownership, and advancements in vaccine technology.

In Vietnam Aquaculture Vaccines Market, offering valuable insights, key market trends, competitive landscape, and future outlook to support strategic decision.

The Vietnamese veterinary medicine vaccines market contracted significantly to $83M in 2024, declining by -15.4% against the previous year. This figure reflects the total revenues of producers and importers (excluding logistics costs, retail marketing costs, and retailers' margins, which will be included in the final consumer price). Overall, the total consumption indicated temperate growth from 2012 to 2024: its value increased at an average annual rate of +4.9% over the last twelve years.

Vietnam Pediatric Vaccines Market growth is driven by increasing demand for vaccines, government support for immunization programs, and technological advancements in vaccine formulations and delivery systems.

Veterinary Vaccines Except for Foot and Mouth Market Size Value in Vietnam, 2021 Discover more data with ReportLinker!

The Global Rabies Veterinary Vaccines Market is expected to grow at a CAGR of approximately 7.5% from 2024 to 2034

In Vietnam Automation Sensors Market, was valued at approximately USD 10.11 billion in 2022 and is projected to reach USD 12.45 billion by 2029, registering a Compound Annual Growth Rate (CAGR) of 8.65% during the forecast period.

In 2023, the rate of children immunized against measles in the age group of 12 to 23 months in Vietnam decreased by six percentage points (-6.82 percent) compared to 2022. Therefore, the rate of children in Vietnam saw its lowest number in that year with 82 percent. The measles immunization rate of children measures the share of children aged 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of the vaccine.Find more statistics on other topics about Vietnam with key insights such as share of children aged 12-23 months immunized against diphtheria, pertussis and tetanus (DPT), crude birth rate, and number of tuberculosis infections .

Vietnam Therapeutic Vaccines Market is poised for substantial growth, driven by technological advancements, increasing incidences of chronic diseases.

The share of children aged 12-23 months immunized against diphtheria, pertussis and tetanus (DPT) in Vietnam decreased by 26 percentage points (-28.57 percent) compared to the previous year. In 2023, the share of children thereby reached its lowest value in recent years. Child immunization, DPT, measures the percentage of children ages 12 to 23 months who received DPT vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against diphtheria, pertussis (or whooping cough), and tetanus (DPT) after receiving three doses of vaccine.Find more statistics on other topics about Vietnam with key insights such as death rate, infant mortality rate, and female smoking rate.

Vietnam Typhoid Therapeutics Market was valued at USD 48.40 million in 2023 and is anticipated to reach USD 123.46 Million with a CAGR of 4.24% through the forecast period.

In US Aquaculture Vaccines Market, offering valuable insights, key market trends, competitive landscape, and future outlook to support strategic decision.

ベトナム肺炎球菌ワクチン市場は、2024年に1億820万米ドルと評価され、2033年までに2億2050万米ドルに達すると予想され、2025年から2033年までの予測期間中に8.23%の複合年間成長率(CAGR)で成長しています。 肺炎球菌ワクチンは、肺炎、髄膜炎、菌血症などの肺炎連鎖球菌によって引き起こされる重度の感染症を予防する上で重要な役割を果たします。 これらのワクチンは、感染率を低下させ、死亡率を低下させ、入院の必要性を減らし、公衆衛生の保護を確保するために、ベトナムで広く採用されています。

Aquaculture Healthcare Market Outlook

The global aquaculture healthcare market size is projected to grow substantially from USD 1.2 billion in 2023 to USD 2.9 billion by 2032, exhibiting a robust CAGR of 10.4% during the forecast period. This growth trajectory is driven by heightened demand for seafood, improvements in aquaculture practices, and the rising prevalence of aquatic diseases necessitating advanced healthcare solutions.

One of the principal growth factors for the aquaculture healthcare market is the burgeoning global population, which has led to an exponential increase in seafood consumption. As wild fish stocks decline due to overfishing, aquaculture has emerged as a sustainable solution to meet the growing demand. This shift necessitates the implementation of advanced healthcare measures to ensure the health and productivity of farmed aquatic animals. Innovations in vaccines, parasiticides, and feed additives are crucial for maintaining the health of aquaculture species and ensuring the industry's sustainability.

Technological advancements in aquaculture healthcare are also propelling market growth. Enhanced diagnostic tools, such as molecular techniques and rapid diagnostic kits, enable early detection and management of diseases in aquaculture settings. These innovations help in minimizing the spread of infectious diseases, which can cause significant economic losses. Additionally, the development of specialized vaccines and biosecurity measures is playing a vital role in disease prevention, thus driving the market forward.

The increased investment in aquaculture by both public and private sectors is another significant growth driver. Governments across the globe are implementing supportive policies and providing financial aids to encourage sustainable aquaculture practices. Private investments are also flowing into the sector, focusing on research and development to improve healthcare solutions. This influx of funding is fostering innovation and expanding the availability of advanced healthcare products for aquaculture.

Fish Vaccine development is becoming increasingly important as the aquaculture industry expands. Vaccines offer a proactive approach to managing fish health, reducing the reliance on antibiotics and minimizing the risk of disease outbreaks. The development of vaccines tailored to specific fish species and diseases is crucial for enhancing the sustainability of aquaculture operations. These vaccines not only protect fish from common pathogens but also improve their overall growth and productivity. As research continues to advance, the aquaculture industry is likely to see more innovative vaccine solutions that address emerging health challenges, ensuring the long-term viability of fish farming.

Regionally, Asia Pacific holds the largest share of the aquaculture healthcare market, driven by countries like China, India, and Vietnam, which are prominent players in global aquaculture production. The region's dominance is attributed to the large-scale aquaculture activities, supportive government policies, and increasing awareness about the importance of aquatic animal health. North America and Europe are also significant markets, with growing investments in sustainable aquaculture practices and advanced healthcare solutions.

Product Type Analysis

The aquaculture healthcare market is segmented by product type, including vaccines, parasiticides, anti-infectives, medicated feed additives, and others. Vaccines are a critical segment, owing to their role in preventive healthcare. The development of vaccines tailored to specific diseases and species has revolutionized disease management in aquaculture. Advances in biotechnology have led to more effective and targeted vaccines, which are crucial for preventing outbreaks and reducing the need for antibiotics and other treatments.

Parasiticides are another essential product type, addressing the issue of parasitic infestations that can devastate aquaculture populations. The development of new and more effective parasiticides is driven by the need to manage resistance and improve the efficacy of treatments. These products are vital for maintaining the health and productivity of aquaculture systems, particularly in regions with high parasite prevalence.

Anti-infectives, including antibiotics and antimicrobial agents, play a significant role in the treatment of bacterial and fungal infections in aqu

In Vietnam Poultry Vaccines Market , was valued at approximately USD 10.11 billion in 2022 and is projected to reach USD 12.45 billion by 2029, registering a Compound Annual Growth Rate (CAGR) of 8.65% during the forecast period.

In Vietnam Vaccine Glass Packaging Market, The routine vaccination segment is expected to remain a primary consumer of vaccine glass packaging.